Henry Schein Inc (HSIC)
Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell
$72.50
Buy
$75.28
$0.90 (+1.23%)
Prices updated at 03 Apr 2026, 00:31 EDT
| Prices minimum 15 mins delay
Prices in USD
Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Distribution
Chairman
Mr. Stanley M. Bergman
CEO
Mr. R. Steven Boggan
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
25,000
Head office
135 Duryea Road
Melville
United States
11747
Key personnel
Owner name | Salary |
|---|---|
Mr. Stanley M. Bergman Chairman of the Board | 1.69m |
Mr. Frederick M. Lowery Director and Chief Executive Officer | - |
Dr. Bradley T. Sheares, PhD Independent Director | 0.14m |
Ms. Deborah M. Derby Independent Director | 0.14m |
Mr. Joseph L. Herring Independent Director | 0.17m |
Mr. Kurt P. Kuehn Independent Director | 0.16m |
Mr. Mark E. Mlotek Executive Vice President and Chief Strategic Officer | 0.74m |
Mr. Philip A. Laskawy Lead Independent Director | 0.17m |
Mr. William K. Daniel Independent Director | - |
Mr. Robert J. Hombach Independent Director | - |
Dr. Reed V. Tuckson, M.D. Independent Director | 0.11m |
Mr. Michael S. Ettinger Executive Vice President and Chief Operating Officer | 0.73m |
Mr. Mohamad Ali Independent Director | 0.12m |
Mr. Max C. Lin Independent Director | - |
Ms. Anne H. Margulies Independent Director | 0.14m |
Mr. Christopher Pendergast Senior Vice President and Chief Technology Officer | - |
Mr. James Mullins Senior Vice President, Global Supply Chain | - |
Mr. Scott P. Serota Independent Director | 0.12m |
Ms. Carole T. Faig Independent Director | 0.11m |
Mr. Ronald N. South Senior Vice President, Principal Accounting Officer and Chief Financial Officer | 0.63m |
Mr. Andrea Albertini Chief Executive Officer, Global Distribution and Technology | - |
Ms. Kelly Murphy Senior Vice President and General Counsel | - |
Mr. Tom Popeck Chief Executive Officer, Henry Schein Products Group | - |
Mr. R. Steven Boggan Chief Executive Officer, Global Oral Reconstruction Group, Americas | - |
Ms. Christine Sheehy Senior Vice President and Chief Human Resources Officer | - |
Mr. David Kochman Senior Vice President and Chief Corporate Affairs Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Kohlberg Kravis Roberts & Co LP | 15,652,032 |
| JPMorgan Chase & Co | 12,417,540 |
| Vanguard Group Inc | 11,588,199 |
| BlackRock Inc | 6,676,650 |
| Artisan Partners Limited Partnership | 6,647,378 |
Director dealings
Date | Action |
|---|---|
| 10 Dec 2025 | - |
| 25 Nov 2025 | - |
| 24 Nov 2025 | - |
| 19 Nov 2025 | - |
| 13 Nov 2025 | - |
| 10 Sep 2025 | - |
| 13 Aug 2025 | - |
| 07 Aug 2025 | - |
| 13 Jun 2025 | - |
| 13 Jun 2025 | - |
| 11 Jun 2025 | - |
| 09 Jun 2025 | - |
| 30 May 2025 | - |
| 21 May 2025 | - |
| 16 May 2025 | - |
| 09 May 2025 | - |
| 19 Mar 2025 | - |
| 19 Mar 2025 | - |
| 18 Mar 2025 | - |
| 19 Mar 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
